Absorption Efter subkutan indgift til patienter med type 2- diabetes, når exenatid medianen for maksimum plasmakoncentration efter 2 timer.
Absorption Following subcutaneous administration to patients with type 2 diabetes, exenatide reaches median peak plasma concentrations in 2 h.